Copyright
©The Author(s) 2016.
World J Obstet Gynecol. Feb 10, 2016; 5(1): 66-72
Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.66
Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.66
Table 1 Recommended values of thyroid stimulating hormone for each trimester
First trimester | 0.1-2.5 mIU/L |
Second trimester | 0.2-3.0 mIU/L |
Third trimester | 0.3-3.0 mIU/L |
Table 2 Studies of subclinical hypothyroidism in pregnancy
Ref. | Design | Method | Result | Conclusion |
Pop et al[23], 1999 | Cohort study | 220 children were evaluated at 10 mo of age. Maternal TSH, FT4 and TPO antibodies were measured at 12 and 32 wk of pregnancy | Children of women with FT4 levels less than the 5th and 10th centiles at 12 wk had lower scores on the Bayley Psychomotor Development Index at 10 mo. No differences were found at 32 wk | FT4 < 10% ile at 12 wk is a risk factor for impaired psychomotor development in offspring |
Haddow et al[7], 1999 | Retrospective | 62 women with high TSH | Children of these women did less well on 15 tests of intelligence. Average decrease in IQ was 4 points | Undiagnosed hypothyroidism adversely affects the fetal neurodevelopment |
Henrichs et al[8], 2010 | Population based cohort | Women with normal TSH and FT4 < 5th and 10th centile. Expressive vocabulary of children was evaluated by mother at 18 and 30 mo | Maternal TSH not related to outcome. Both mild and severe low FT4 associated with higher risk of expressive language delay at all ages. Severe had higher risk of nonverbal cognitive delay | Maternal low FT4 is a risk factor for early childhood cognitive delay |
Lazarus et al[11], 2012 | Randomized prospective | Women in screening group were tested and treated Women in the control group had stored samples which were tested after delivery and received no treatment during pregnancy | No difference in cognitive function between the two groups at 3 yr of age | Screening and treatment for hypothyroidism did not improve neurodevelopmental outcomes in the offspring |
Ghassabian et al[24], 2014 | Cohort | 3727 mother-child pairs with prenatal thyroid fxn tests before 18 wk. FT4 < 5% of normal. MRI of childrens brains and IQ test at age 6 yr | Children of mothers with low FT4 scored 4.3 points lower on nonverbal IQ test. No morphologic difference by MRI | Maternal hypothyroxinemia has adverse effect on children’s non-verbal IQ at school age |
Chen et al[13], 2015 | Prospective | 106 babies born to mothers with SCH and 106 babies born to euthyroid mothers | Babies from both groups had similar scores on the Gesell development test | No neurodevelopmental deficit detected up to 24 mo in babies of mothers with SCH |
Table 3 Diagnosis and treatment of thyroid disease in pregnancy
TSH | FT4 | FT3 | Rx | Goal of treatment | |
Hypothyroid | ↑ | ↓ | ↓ | Levothyroxine starting dose 1-2 mcg/kg daily | Keep TSH normal range |
Hyperthyroid | ↓ | ↑ | ↑ | PTU 50-150 mg TID in first trimester methimazole 10-40 mg BID or TID after first trimester | Keep FT4 high normal “watch for agranulocytosis” |
Table 4 Six steps for treatment of thyroid storm
1 Admit to intensive care unit | IV fluids and watch electrolytes |
2 Tylenol 650 mg q6 h | For hyperpyrexia |
3 Loading dose of 1000 mg PTU orally then 200 mg orally q6 h; alternate dosing 300 mg PTU q6 h | Will block synthesis of T3 and T4 |
4 Iodine supplementation 10 drops of Lugol’s solution q8 h OR 1 g sodium Iodide IV q8-12 h Iodine allergy use lithium carbonate 300 mg PO q6 h | Blocks release of hormone from the thyroid gland |
5 Hydrocortisone 50-80 mg q8 h for 3 doses OR Dexamethasone 2 mg IV q6 h for 4 doses | To block peripheral conversion of T4 to T3 |
6 Beta blocker Labetolol 300 mg TID may increase to a max dose of 800 mg TID but watch blood pressure | To control the tachycardia – use cautiously in heart failure |
Table 5 Frequency of antenatal surveillance
Ultrasound | Antenatal testing (Nonstress test or Biophysical Profile) | |
Hyperthyroid | Monthly | Twice weekly if poorly controlled |
Hypothyroid | No recommendation Consider monthly | No recommendation |
- Citation: Moore LE. Thyroid disease in pregnancy: A review of diagnosis, complications and management. World J Obstet Gynecol 2016; 5(1): 66-72
- URL: https://www.wjgnet.com/2218-6220/full/v5/i1/66.htm
- DOI: https://dx.doi.org/10.5317/wjog.v5.i1.66